What is Viloxazine Hydrochloride? What diseases are it mainly used to treat?

Viloxazine is a new selective norepinephrine reuptake inhibitor (NRI), originally developed as an antidepressant and currently approved in many countries for the treatment of attention deficit hyperactivity disorder (ADHD). The drug helps improve inattention, hyperactivity and impulsive behavior by increasing the level of norepinephrine in the brain, and is particularly suitable for children and adolescent patients. Unlike traditional central nervous system stimulants, veloxazine does not contain stimulant ingredients, has relatively mild side effects, and has a low risk of addiction. It is suitable for patients who are sensitive to or contraindicated with stimulant drugs. In addition, veloxazine also has certain antidepressant and anxiety-relieving effects, and is suitable for patients with ADHD combined with mood disorders.